Nasopharyngeal Carcinoma: Recent Advances in Clinical Diagnosis and Treatment
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Otolaryngology".
Deadline for manuscript submissions: 15 April 2026 | Viewed by 12
Special Issue Editor
Interests: head and neck oncology; rhinology; ENT
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
This Special Issue aims to highlight recent progress in the understanding, diagnosis, and treatment of nasopharyngeal carcinoma (NPC), a malignancy with distinct epidemiological, biological, and clinical features. Despite improvements in imaging and radiotherapy techniques, challenges remain in the early detection, risk stratification, and management of recurrent or metastatic disease. The core problems to be addressed include limited biomarkers for accurate screening, the optimization of combined therapeutic strategies, and the need for novel targeted and immunotherapeutic approaches.
The scope of this Special Issue encompasses original research, clinical studies, and reviews focusing on diagnostic innovations, prognostic indicators, radiotherapy advancements, systemic therapy developments, and the integration of personalized medicine into NPC care.
Researchers, clinicians, and translational scientists are invited to contribute work that advances understanding and fosters multidisciplinary solutions, ultimately aiming to improve patient outcomes and shape future standards of care in NPC management.
Dr. Federico Sireci
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nasopharyngeal carcinoma
- early diagnosis
- radiotherapy advances
- immunotherapy
- targeted therapy
- biomarkers
- precision medicine
- recurrence and metastasis management
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
